SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-069017
Filing Date
2022-06-07
Accepted
2022-06-07 17:08:39
Documents
4
Period of Report
2022-08-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2217544-1_pre14a.htm PRE 14A 656149
2 GRAPHIC lg_vynethera-4c.jpg GRAPHIC 58250
3 GRAPHIC tm2217544d1-px_01vynebw.jpg GRAPHIC 818023
4 GRAPHIC tm2217544d1-px_02vyne4c.jpg GRAPHIC 378124
  Complete submission text file 0001104659-22-069017.txt   2385167
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38356 | Film No.: 221001884
SIC: 2834 Pharmaceutical Preparations